Literature DB >> 1712488

Multiple overlapping homologies between two rheumatoid antigens and immunosuppressive viruses.

A Douvas1, S Sobelman.   

Abstract

Amino acid (aa) sequence homologies between viruses and autoimmune nuclear antigens are suggestive of viral involvement in disorders such as systemic lupus erythematosus (SLE) and scleroderma. We analyzed the frequency of exact homologies of greater than or equal to 5 aa between 61 viral proteins (19,827 aa), 8 nuclear antigens (3813 aa), and 41 control proteins (11,743 aa). Both pentamer and hexamer homologies between control proteins and viruses are unexpectedly abundant, with hexamer matches occurring in 1 of 3 control proteins (or once every 769 aa). However, 2 nuclear antigens, the SLE-associated 70-kDa antigen and the scleroderma-associated CENP-B protein, are highly unusual in containing multiple homologies to a group of synergizing immunosuppressive viruses. Two viruses, herpes simplex virus 1 (HSV-1) and human immunodeficiency virus 1 (HIV-1), contain sequences exactly duplicated at 15 sites in the 70-kDa antigen and at 10 sites in CENP-B protein. The immediate-early (IE) protein of HSV-1, which activates HIV-1 regulatory functions, contains three homologies to the 70-kDa antigen (two hexamers and a pentamer) and two to CENP-B (a hexamer and pentamer). There are four homologies (including a hexamer) common to the 70-kDa antigen and Epstein-Barr virus, and three homologies (including two hexamers) common to CENP-B and cytomegalovirus. The majority of homologies in both nuclear antigens are clustered in highly charged C-terminal domains containing epitopes for human autoantibodies. Furthermore, most homologies have a contiguous or overlapping distribution, thereby creating a high density of potential epitopes. In addition to the exact homologies tabulated, motifs of matching sequences are repeated frequently in these domains. Our analysis suggests that coexpression of heterologous viruses having common immunosuppressive functions may generate autoantibodies cross-reacting with certain nuclear proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712488      PMCID: PMC52076          DOI: 10.1073/pnas.88.14.6328

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

Review 1.  Potential role of Epstein-Barr virus in Sjögren's syndrome.

Authors:  R I Fox; T Chilton; S Scott; L Benton; F V Howell; J H Vaughan
Journal:  Rheum Dis Clin North Am       Date:  1987-08       Impact factor: 2.670

2.  [What is the role of Epstein-Barr virus in the pathogenesis of connective tissue diseases?].

Authors:  J Sany
Journal:  Presse Med       Date:  1987-04-25       Impact factor: 1.228

3.  Aberrant splicing events that are induced by proviral integration: implications for myb oncogene activation.

Authors:  D Rosson; D Dugan; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.

Authors:  J Garnier; D J Osguthorpe; B Robson
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

5.  Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-kappa B/core enhancer sequence.

Authors:  J M Gimble; E Duh; J M Ostrove; H E Gendelman; E E Max; A B Rabson
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

Review 6.  Epstein-Barr virus and human autoimmune diseases: possibilities and pitfalls.

Authors:  R Fox
Journal:  J Virol Methods       Date:  1988-09       Impact factor: 2.014

7.  Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus.

Authors:  P R Skolnik; B R Kosloff; M S Hirsch
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

8.  Antibodies to rheumatoid arthritis nuclear antigen (RANA) in Japanese patients with rheumatoid arthritis.

Authors:  K Nakabayashi; M Saito; T Nagasawa; M Takada
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

9.  Human U1 snRNP-specific C protein: complete cDNA and protein sequence and identification of a multigene family in mammals.

Authors:  P T Sillekens; R P Beijer; W J Habets; W J van Venrooij
Journal:  Nucleic Acids Res       Date:  1988-09-12       Impact factor: 16.971

10.  Cloning of the human cDNA for the U1 RNA-associated 70K protein.

Authors:  H Theissen; M Etzerodt; R Reuter; C Schneider; F Lottspeich; P Argos; R Lührmann; L Philipson
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

View more
  5 in total

1.  cDNA cloning and characterization of the protein encoded by RD, a gene located in the class III region of the human major histocompatibility complex.

Authors:  J Cheng; K J Macon; J E Volanakis
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

2.  Amelioration of experimental systemic lupus erythematosus (SLE) by retrovirus infection.

Authors:  B B Mittleman; H C Morse; S M Payne; G M Shearer; E Mozes
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

3.  Cytomegalovirus immediate early genes prevent the inhibitory effect of cyclosporin A on interleukin 2 gene transcription.

Authors:  L J Geist; M M Monick; M F Stinski; G W Hunninghake
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

Review 4.  Retroviruses and autoimmune rheumatic diseases.

Authors:  J R Kalden; S Gay
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

5.  Infections are not increased in scleroderma compared to non-inflammatory musculoskeletal disorders prior to disease onset.

Authors:  Janet E Pope; Jodi L Goodwin; Janine M Ouimet; Adriana Krizova; Matthew Laskin
Journal:  Open Rheumatol J       Date:  2007-11-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.